Global Patent Index - EP 4308074 A1

EP 4308074 A1 20240124 - COMPOSITE OROMUCOSAL FILM COMPOSITIONS COMPRISING EPINEPHRINE PARTICLES

Title (en)

COMPOSITE OROMUCOSAL FILM COMPOSITIONS COMPRISING EPINEPHRINE PARTICLES

Title (de)

ZUSAMMENGESETZTE OROMUKOSALE FILMZUSAMMENSETZUNGEN MIT EPINEPHRINPARTIKELN

Title (fr)

COMPOSITIONS DE FILM BUCCAL COMPOSITE COMPRENANT DES PARTICULES D'ÉPINÉPHRINE

Publication

EP 4308074 A1 20240124 (EN)

Application

EP 22712071 A 20220317

Priority

  • US 202163161976 P 20210316
  • IB 2022052411 W 20220317

Abstract (en)

[origin: WO2022195521A1] The invention provides an oromucosal film composition comprising: a therapeutically effective amount of epinephrine solid particles having a particle size in the range of from about 0.01 um to about 100 um; and a pharmaceutically acceptable polymer wherein the epinephrine solid particles are dispersed in and/or disposed on a polymeric layer. The film compositions can be used for the treatment of anaphylactic shock, cardiac arrest, asthma, bronchial asthma, bronchitis, emphysema, respiratory infections, and allergic reactions. The film compositions may further contain local anesthetics and used for providing local anesthesia, such as for the treatment or prevention of tooth pain.

IPC 8 full level

A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61K 31/00 (2006.01); A61K 45/06 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61P 1/00 (2006.01); B29C 64/00 (2017.01); B33Y 80/00 (2015.01)

CPC (source: EP GB US)

A61K 9/006 (2013.01 - EP GB US); A61K 9/7007 (2013.01 - EP GB US); A61K 31/137 (2013.01 - EP GB US); A61K 31/167 (2013.01 - EP GB US); A61K 31/381 (2013.01 - US); A61K 31/445 (2013.01 - US); A61K 31/5513 (2013.01 - US); A61K 31/5517 (2013.01 - US); A61K 31/569 (2013.01 - US); A61K 38/26 (2013.01 - US); A61K 45/06 (2013.01 - EP GB); A61K 47/02 (2013.01 - EP GB); A61K 47/10 (2013.01 - EP GB US); A61K 47/12 (2013.01 - EP GB); A61K 47/32 (2013.01 - EP GB); A61K 47/38 (2013.01 - EP GB US); A61P 1/00 (2017.12 - EP GB); A61P 23/02 (2017.12 - EP GB); B33Y 10/00 (2014.12 - EP GB); B33Y 70/10 (2020.01 - EP GB); B33Y 80/00 (2014.12 - EP GB)

C-Set (source: EP)

  1. A61K 31/167 + A61K 2300/00
  2. A61K 31/137 + A61K 2300/00

Citation (search report)

See references of WO 2022195521A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2022195521 A1 20220922; AU 2022241136 A1 20231109; BR 112023018833 A2 20231226; CA 3212569 A1 20220922; EP 4308074 A1 20240124; GB 202315814 D0 20231129; GB 2620085 A 20231227; JP 2024510035 A 20240305; MX 2023010953 A 20231208; US 2023119239 A1 20230420; US 2023123134 A1 20230420; US 2023157950 A1 20230525

DOCDB simple family (application)

IB 2022052411 W 20220317; AU 2022241136 A 20220317; BR 112023018833 A 20220317; CA 3212569 A 20220317; EP 22712071 A 20220317; GB 202315814 A 20220317; JP 2023557662 A 20220317; MX 2023010953 A 20220317; US 202217934198 A 20220921; US 202217934566 A 20220922; US 202318159320 A 20230125